These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 12569265

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by alpha1-adrenoceptor antagonism.
    van der Linde NA, Boomsma F, van den Meiracker AH.
    J Hypertens; 2005 May; 23(5):1017-24. PubMed ID: 15834288
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
    Montanari A, Pelà G, Musiari L, Crocamo A, Boeti L, Cabassi A, Biggi A, Cherney DZ.
    Am J Physiol Renal Physiol; 2013 Jul 01; 305(1):F42-51. PubMed ID: 23657857
    [Abstract] [Full Text] [Related]

  • 4. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME.
    Broere A, Van Den Meiracker AH, Boomsma F, Derkx FH, Veld AJ, Schalekamp MA.
    Am J Physiol; 1998 Dec 01; 275(6):F870-7. PubMed ID: 9843903
    [Abstract] [Full Text] [Related]

  • 5. Calcium channel blockade blunts the renal effects of acute nitric oxide synthase inhibition in healthy humans.
    Montanari A, Lazzeroni D, Pelà G, Crocamo A, Lytvyn Y, Musiari L, Cabassi A, Cherney DZI.
    Am J Physiol Renal Physiol; 2017 May 01; 312(5):F870-F878. PubMed ID: 28179255
    [Abstract] [Full Text] [Related]

  • 6. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
    Kramer HJ, Horacek V, Bäcker A, Vaneckova I, Heller J.
    Kidney Blood Press Res; 2004 May 01; 27(1):10-7. PubMed ID: 14583658
    [Abstract] [Full Text] [Related]

  • 7. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.
    Sigmon DH, Beierwaltes WH.
    Hypertension; 1998 Feb 01; 31(2):649-56. PubMed ID: 9461236
    [Abstract] [Full Text] [Related]

  • 8. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock.
    Boffa JJ, Arendshorst WJ.
    J Am Soc Nephrol; 2005 Jan 01; 16(1):117-24. PubMed ID: 15563566
    [Abstract] [Full Text] [Related]

  • 9. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats.
    Ono Y, Ono H, Frohlich ED.
    J Hypertens; 1996 Jul 01; 14(7):823-8. PubMed ID: 8818920
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II and prostaglandin interactions on systemic and renal effects of L-NAME in humans.
    Perinotto P, Biggi A, Carra N, Orrico A, Valmadre G, Dall'aglio P, Novarini A, Montanari A.
    J Am Soc Nephrol; 2001 Aug 01; 12(8):1706-1712. PubMed ID: 11461943
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans.
    Montanari A, Tateo E, Fasoli E, Giberti D, Perinotto P, Novarini A, Dall'Aglio P.
    Hypertension; 1997 Sep 01; 30(3 Pt 2):557-62. PubMed ID: 9322981
    [Abstract] [Full Text] [Related]

  • 12. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct 01; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 13. Dopamine-2 receptor blockade potentiates the renal effects of nitric oxide inhibition in humans.
    Montanari A, Tateo E, Fasoli E, Donatini A, Cimolato B, Perinotto P, Dall'Aglio P.
    Hypertension; 1998 Jan 01; 31(1 Pt 2):277-82. PubMed ID: 9453316
    [Abstract] [Full Text] [Related]

  • 14. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS, Clark KL, Johns EJ, Drew GM.
    Br J Pharmacol; 1998 Aug 01; 124(7):1467-74. PubMed ID: 9723960
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
    Bech JN, Nielsen CB, Pedersen EB.
    Am J Physiol; 1996 May 01; 270(5 Pt 2):F845-51. PubMed ID: 8928847
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats.
    Lee BH, Shin HS.
    Jpn J Pharmacol; 1997 May 01; 74(1):83-90. PubMed ID: 9195301
    [Abstract] [Full Text] [Related]

  • 19. Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice.
    Shahid M, Francis J, Matrougui K, Majid DS.
    Am J Physiol Renal Physiol; 2010 Jul 01; 299(1):F217-24. PubMed ID: 20410217
    [Abstract] [Full Text] [Related]

  • 20. Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure.
    Lahera V, Salom MG, Miranda-Guardiola F, Moncada S, Romero JC.
    Am J Physiol; 1991 Dec 01; 261(6 Pt 2):F1033-7. PubMed ID: 1750517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.